Friday, October 30, 2026 · Edition updated 6:00 AM ETFRI, OCT 30 · 6 AM ET editionNext edition in Next --:--:--

Protein NEDD4 may protect disc cells from aging and cell death in a lab test

A study · The Journal of international medical research · Oct 27, 2026

What this means

Researchers grew disc cells in a dish with an inflammation signal. Boosting NEDD4 eased aging and cell death, and it broke down another protein called PTEN. More tests in living animals and more checks are still needed.

Plain-English summary written by an AI model from the abstract. The original is below.

Tested inCells in a lab
Who it was tested in
Two types of human disc cells grown in a lab dish
Kind of research
A study

The science

Original title
Neural precursor cell expressed developmentally downregulated 4-mediated phosphatase and tensin homolog ubiquitination alleviates senescence and apoptosis of nucleus pulposus cells under interleukin-1 beta conditions.
Authors
Lin Y, Li C, Chang X et al.
Journal
The Journal of international medical research
Published
Oct 27, 2026
Study type
Study · in humans

Abstract

ObjectiveIncreasing evidence indicates that aging and apoptosis of nucleus pulposus cells are closely associated with the pathogenesis of intervertebral disc degeneration. This study investigated the role of E3 ubiquitin ligase neural precursor cell expressed developmentally downregulated gene 4 (NEDD4) in the interleukin-1 beta-induced aging and apoptosis of human nucleus pulposus cells and evaluated whether NEDD4 mediates these effects by promoting the ubiquitination and degradation of phosphatase and tensin homolog (PTEN).MethodsTwo commercially available immortalized human nucleus pulposus cells were used for in vitro experiments, without involving human participants or collecting human tissues. The cells were treated with interleukin-1 beta (10 ng/mL for 24 h) to establish an inflammatory model of intervertebral disc degeneration. Transfection of overexpressed NEDD4 and/or PTEN was performed in the model cells. Cell viability, apoptosis, senescence, oxidative stress, inflammatory mediators, and extracellular matrix-related proteins were assessed. The interactions between NEDD4 and PTEN and the stability of the PTEN protein were investigated using co-immunoprecipitation, actinomycin D tracking, MG132 treatment, and intracellular ubiquitination experiments.ResultsInterleukin-1 beta treatment downregulated NEDD4 expression in nucleus pulposus cells to 2.3-fold of the baseline level (p < 0.001) while simultaneously upregulated PTEN protein expression to 1.8-fold of the baseline level (p < 0.01). Overexpression of NEDD4 shortened the half-life of PTEN protein from 8 h to 3 h through the ubiquitin-proteasome-dependent degradation pathway (p < 0.001). In addition, overexpression of NEDD4 reduced the level of reactive oxygen species, inhibited cell apoptosis, decreased the expression levels of p21 and p16, and restored the expression levels of type II collagen and aggrecan (p < 0.05). NEDD4 interacted with PTEN and enhanced its ubiquitination. Functional rescue experiments indicated that overexpression of PTEN weakened the protective effects of NEDD4.ConclusionsThis study preliminarily demonstrated that the overexpression of NEDD4 can alleviate the interleukin-1 beta-induced apoptosis and senescence phenomena of nucleus pulposus cells. This effect may be partially mediated by promoting the ubiquitination of PTEN and the proteasome degradation pathway. However, further functional deficiency experiments and in vivo validations are warranted to establish the causal relationship and therapeutic relevance.

Read it on PubMed ↗

Lin Y, Li C, Chang X et al. Neural precursor cell expressed developmentally downregulated 4-mediated phosphatase and tensin homolog ubiquitination alleviates senescence and apoptosis of nucleus pulposus cells under interleukin-1 beta conditions. The Journal of international medical research. 2026. doi:10.1177/03000605261499771. PMID: 42946644. https://pubmed.ncbi.nlm.nih.gov/42946644/

Related research

PeopleClinical trial · American journal of physiology. Renal physiology · Oct 26, 2026

Home exercise may change muscle in people with kidney disease

A small trial found changes in muscle blood vessels and fewer fibrosis-linked cells after 12 weeks of home exercise. Only 25 people took part, so this does not prove the exercise caused lasting muscle benefits.

Summary of earlier studiesReview · Current sports medicine reports · Jul 1, 2026

Effects of Supplementation in Masters Athletes and Older Adults: A Narrative Review.

Supplementation use in athletes is common and increasing in popularity, especially for adults seeking improvements in athletic performance.

Study · Archives of internal medicine research · Sep 25, 2026

Review of copper peptide GHK-Cu studies finds many lab results but few human trials

Researchers read 64 studies on GHK-Cu, a copper-linked peptide, and found much lab and animal work. They say well-designed human trials using microneedles are still needed.

Study · Aesthetic surgery journal · Aug 20, 2026

Review of a copper peptide used in skin treatments

Researchers reviewed 20 studies on GHK-Cu, a copper peptide, for skin and beauty uses. Most were lab or animal studies, and only two were human trials, so more strong testing is still needed.

AnimalsStudy · Uterine research · Oct 27, 2026

Uterine function and reproduction aging. I. Molecular and structural alterations associated with impaired decidualization in aged mouse uteri.

Reproductive aging is associated with reduced fertility and increased risk of adverse pregnancy outcomes, including miscarriage, placental dysfunction, and fetal growth restriction.

Study · The Journal of nutrition · Oct 26, 2026

Hydroxyproline with amino acids extended worm lifespan in lab tests

Researchers gave worms hydroxyproline plus three amino acids and saw longer life and better health markers. This was tested under set lab conditions, so it does not show the same effect in people.

See all research on Collagen peptides →

Report a problem